Diagnosis of hypercoagulability is by. Molecular markers
|
|
- Betty Theodora Cole
- 5 years ago
- Views:
Transcription
1 Agenda limitations of clinical laboratories to evaluate hypercoagulability and the underlying cause for thrombosis what is the INR the lupus anticoagulant and the antiphospholipid antibody syndrome hassouna 1
2 Diagnosis of hypercoagulability is by Molecular markers Are products of clotting and fibrinolysis reactions Diagnosis of hypercoagulability is by antibodies raised against molecular markers F1+2 fragment, TAT, FPA, D-dimer, t-pa and thrombomodulin hassouna 2
3 Fibrinolysis Mechanisms When crosslinked fibrin undergoes fibrinolysis, the peptides joining D- and E- domains are cleaved, leading to fibrin split products. Tetramolecular Branch Point D-tetramer D-trimer Trimolecular Branch Point D-dime r Fibr inolysis Plasmin D-dime r Fibrin tpa Pg E D-trimer DY D-tetramer hassouna 3
4 Molecular Markers Except for D-dimer molecular markers are not tested in clinical laboratories hassouna 4
5 Diagnosis of thrombosis By clinical signs and symptoms by radiographic, ultrasound,or magnetic resonance Imaging Laboratory testing is used to diagnose the underlying cause for thrombosis hassouna 5
6 Underlying cause for Vascular Occlusion is not always thrombosis thrombosis: clots in circulating blood are created by abnormal thrombin activity embolism: dislodged clot or plaque impaired clot lysis: persistence of blood clot in circulating blood hassouna 6
7 Underlying Mechanism of Vascular Occlusion Clots in circulating blood are created by abnormal thrombin activity hassouna 7
8 Abnormal thrombin activity DIC acute and chronic surgery, obstetrics, burns infections etc antiphospholipid antibody syndrome hassouna 8
9 Tissue factor Is not present in circulating blood is encrypted in cell membranes is de-encrypted by injury to cells de-encrypted tissue factor becomes the factor VII receptor factor VII bound to tissue factor initiates clotting reactions hassouna 9
10 Initiation of clotting reactions TF. TF. FVII FVII complex complex FVII FVII dark dark blue blue soluble soluble TF TF light light blue blue Gla Gla residues residues yellow yellow hassouna 10
11 Thrombin active site cleft hassouna 11
12 Schematic Model of Native Fibrinogen Fibrinogen is a symmetric dimeric structure consisting of three pairs of non-identical polypeptide chains Aa, Bb and g. b FPA a g FPB a r PI Fibrinogen fxiii g a hassouna 12 b
13 Fibrin Assembly: Non-covalent interaction between E- and D-domains This type of fibrin is extremely susceptible to degradation. b IIa a a r PI g Fibrin tpa fxiii g a b D-domain E-domain D-domain hassouna 13
14 Underlying Mechanism of Vascular Occlusion impaired clot lysis: persistence of blood clot in circulating blood hassouna 14
15 Impaired clot lysis Decreased plasminogen levels abnormal plasminogen-fibrinogen interactions decreased T-PA activity increased PAI-1 decreased FXII and prekallikrein activities atherosclerosis hassouna 15
16 Cause for abnormal thrombin activity Decreased potential to inhibit thrombin activity hassouna 16
17 Acquired and inherited deficiencies antithrombin protein C protein S factor V Leiden G20210A polymorphism is complicated by variable clinical expression in family members with identical genotypes hassouna 17
18 Antithrombin A representation of the heparin pentasaccharide binding site showing the D-helix (red) and the A-helix (green) and the side chains of the pentasaccharide binding residues (blue) A representation of the heparin pentasaccharide binding site showing the D-helix (green) and the side- chains of the pentasaccharide binding residues (blue) hassouna 18
19 Biologically active domains in procoagulant factors hassouna 19
20 hassouna 20
21 Activity, concentration,gene structure hassouna 21
22 Agenda Limitations of Clinical tests in the diagnosis of thrombosis hassouna 22
23 hassouna 23
24 Clinical assays hassouna 24
25 Clinical Assays hassouna 25
26 What is the INR Is it a clotting test is it the time in sec for plasma to clot is it the time in sec for blood to clo hassouna 26
27 TF. TF. FVII FVII complex complex FVII FVII dark dark blue blue soluble soluble TF TF light light blue blue Gla Gla residues residues yellow yellow hassouna 27
28 The prothrombin time test (PT) tissue factor from rabbit brain and calcium chloride 200 L are added to plasma 100 L and the time taken for a clot to form is recorded on a photo-optical instrument. The clotting time of the same plasma differs from one equipment to the other hassouna 28
29 The prothrombin time test Two decades ago, the prothrombin time reagent was prepared with rabbit, ox or human brain thromboplastin. The affinity of rabbit, ox and human thromboplastin for human plasma factor VII in the PT assay varies by as much as 10 sec rabbit: sec human: 23-26sec ox: sec hassouna 29
30 What is the INR Each thromboplastin reagent receives an International Sensitivity Index or IS I IS I is a value that indicates the affinity of a thromboplastin for human plasma factor VII The prothrombin time ratio or PTR is the clotting time of pooled normal plasma divided by that of the patient plasma. The International Normalized Ratio or INR is a value not a clotting time calculated by raising the PTR to the power of the IS I hassouna 30
31 INR Limitations The indicated use of the INR is exclusively for patients stabilized on coumadin. The INR is not interchangeable with a clotting time If a patient is not on coumadin the INR is obsolete hassouna 31
32 Concentrations of Vitamin-K dependent factors mg/l are only slightly decreased with coumadin Prothrombin Protein S Factor X Factor IX Protein C Factor VII hassouna 32
33 Factor VII polymorphism hassouna 33
34 Extrinsic Pathway Extrinsic Rabbit Tissue Factor + Ca Cl2 Human factor VII + + Ca ++ Common hassouna 34
35 Cause for abnormal thrombin activity A genetic mutation causing increased prothrombin levels in blood results in increased thrombin activity hassouna 35
36 Activity, concentration and gene structure hassouna 36
37 hassouna 37
38 hassouna 38
39 Prothrombin mutation G20210A Prothrombin is a zymogen ( it cannot form a clot, it is the precursor of an enzyme. It is converted to thrombin by initiation of clotting Clotting is initiated by tissue factor tissue factor is encrypted in cells and does not circulate in blood hassouna 39
40 Thrombin is released from prothrombin by catalytic reactions on negatively charged membrane surfaces hassouna 40
41 Initiation of clotting reactions TF. TF. FVII FVII complex complex FVII FVII dark dark blue blue soluble soluble TF TF light light blue blue Gla Gla residues residues yellow yellow hassouna 41
42 hassouna 42
43 More than one genetic factor may co-segregate with a consequent synergistic effect on thrombotic risk hassouna 43
44 Lupus Anticoagulant and Antiphospholipid Syndrome hassouna 44
45 Lupus anticoagulant By definition it is a prolonged clotting time in a lipid based clotting assay The cause for the prolonged clotting time is a substance in the patient s plasma that reacts with the lipids in the reagent and inactivates the lipids in the reagent hassouna 45
46 Intrinsic Pathway Contact Activator XII XI XIIa XIa IIa IX VIII IXa + VIIIa + PL + Ca ++ Extrinsic hassouna 46 Common
47 Lupus anticoagulant Cross reacting antibodies against microbial lipid membranes ( most common are antibodies to streptococcus and staphylococcus) cross reacting antibodies against human lipid membranes. Drugs that tie up phospholipids in reagent hassouna 47
48 Coagulation Analyzer hassouna 48
49 Intrinsic Pathway Contact Activator XII XI XIIa XIa IIa IX VIII IXa + VIIIa + PL + Ca ++ Extrinsic hassouna 49 Common
50 Lupus anticoagulant Is not a risk factor for thrombosis indicates a prolonged clotting time that does not correct by mixing the patient plasma with equal volume pooled normal plasma hassouna 50
51 Membrane Phospholipid Antiphospholipid antibodies are antibodies directed against cell membrane phospholipids hassouna 51
52 Platelet Membrane Phospholipid Dense Granule Alpha-granule ADP ß-thromboglobulin Platelet factor 4 Platelet-derived Growth Factor Fibrinogen Factor V hassouna 52
53 Antiprothrombin antibodies Are antibodies directed against prothrombin hassouna 53
54 hassouna 54
55 Antiphospholipid antibody syndrome Antiprothrombin antibodies antiphospholipid antibodies anticardiolipin antibodies phospholipid binding protein beta-2- glycoprotein 1 hassouna 55
56 Antibodies that tie up phospholipid reagents ( lupus anticoagulants) Antiprothrombin antibodies antiphospholipid antibodies anticardiolipin antibodies ( very rare) phospholipid binding protein beta-2- glycoprotein 1 are necessarily a risk factor for thrombosis hassouna 56
57 Lupus anticoagulant Is not a risk factor for thrombosis indicates a prolonged clotting time that does not correct by mixing the patient plasma with equal volume pooled normal plasma hassouna 57
58 Intrinsic Pathway Contact Activator XII XIIa XI XIa IIa IX VIII IXa + VIIIa + PL + Ca ++ Extrinsic hassouna Common 58
59 Extrinsic Pathway Contact Activator XII XIIa TF Extrinsic XI IX VIII XIa IXa + VIIIa + PL + Ca ++ Intrinsic VII VIIa + TF + Ca ++ hassouna 59 Common
60 If a lab reports a lupus anticoagulant, what next Ask for an antiphospholipid antibody test ask for a prothrombin antibody test ask for an anticardiolipin test if positive, the diagnosis is antiphospholipid syndrome, hassouna 60
61 Lupus Anticoagulant and Antiphospholipid Syndrome hassouna 61
62 Antiphospholipid antibody syndrome Must include lupus anticoagulant plus antibodies against prothrombin or phospholipids or cardiolipin antiphospholipid syndrome is diagnosed by clotting assays and by antibody based assays prolonged clotting time without positive antibodies is not a risk factor for thrombosis, miscarriage etc hassouna 62
Part IV Antithrombotics, Anticoagulants and Fibrinolytics
Part IV Antithrombotics, Anticoagulants and Fibrinolytics "The meaning of good and bad, of better and worse, is simply helping or hurting" Emerson Chapter 16: Blood Coagulation and Fibrinolytic System
More informationPrimary Exam Physiology lecture 5. Haemostasis
Primary Exam Physiology lecture 5 Haemostasis Haemostasis Body s response for the prevention and cessation of bleeding. Broadly consists of: Primary Haemostasis - vascular spasm and platlet plug formation
More informationBlood clotting. Subsequent covalent cross-linking of fibrin by a transglutaminase (factor XIII) further stabilizes the thrombus.
Blood clotting It is the conversion, catalyzed by thrombin, of the soluble plasma protein fibrinogen (factor I) into polymeric fibrin, which is deposited as a fibrous network in the primary thrombus. Thrombin
More informationIntroduction to coagulation and laboratory tests
Introduction to coagulation and laboratory tests Marc Jacquemin Special Haemostasis Laboratory Center for Molecular and Vascular Biology University of Leuven Coagulation in a blood vessel: fibrin stabilises
More informationBlood coagulation and fibrinolysis. Blood clotting (HAP unit 5 th )
Blood coagulation and fibrinolysis Blood clotting (HAP unit 5 th ) Vessel injury Antithrombogenic (Favors fluid blood) Thrombogenic (Favors clotting) 3 Major systems involved Vessel wall Endothelium ECM
More informationHemostasis. Learning objectives Dr. Mária Dux. Components: blood vessel wall thrombocytes (platelets) plasma proteins
Hemostasis Learning objectives 14-16 Dr. Mária Dux Components: blood vessel wall thrombocytes (platelets) plasma proteins Hemostatic balance! procoagulating activity anticoagulating activity 1 Thrombocytes
More informationCoagulation an Overview Dr.Abdolreza Abdolr Afrasiabi Thal assem a & Heamophili hilia G ene i tic R esearc C en er Shiraz Medical Medic University
In The Name God Coagulation an Overview Dr.Abdolreza Afrasiabi Thalassemia & Heamophilia Genetic Research hcenter Shiraz Medical University Bleeding Clotting Hemostasis Review of platelet function Platelets
More informationInherited Thrombophilia Testing. George Rodgers, MD, PhD Kristi Smock MD
Inherited Thrombophilia Testing George Rodgers, MD, PhD Kristi Smock MD Prevalence and risk associated with inherited thrombotic disorders Inherited Risk Factor % General Population % Patients w/ Thrombosis
More informationChapter 1. General introduction
Chapter 1 General introduction 8 Haemostasis All organs and tissues of higher organisms are provided with nutrients and oxygen through the bloodstream. The bloodstream is an extensive vascular system that
More informationThursday, February 26, :00 am. Regulation of Coagulation/Disseminated Intravascular Coagulation HEMOSTASIS/THROMBOSIS III
REGULATION OF COAGULATION Introduction HEMOSTASIS/THROMBOSIS III Regulation of Coagulation/Disseminated Coagulation necessary for maintenance of vascular integrity Enough fibrinogen to clot all vessels
More informationUNIT VI. Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav. Copyright 2011 by Saunders, an imprint of Elsevier Inc.
UNIT VI Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav Hemostasis: Prevention of Blood Loss Vascular constriction Formation of a platelet plug Formation of a blood
More informationL iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche
L iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche Armando Tripodi Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Dept. of Clinical Sciences and Community Health University
More informationCh. 45 Blood Plasma proteins, Coagulation and Fibrinolysis Student Learning Outcomes: Describe basic components of plasma
Chapt. 45 Ch. 45 Blood Plasma proteins, Coagulation and Fibrinolysis Student Learning Outcomes: Describe basic components of plasma Inheritance of X-linked gene for Factor VIII hemophilia A Explain the
More informationThrombosis. Jeffrey Jhang, M.D.
Thrombosis Jeffrey Jhang, M.D. Introduction The human hemostatic system has evolved to maintain blood flow under normal physiologic conditions while remaining primed to rapidly respond to vascular injury
More informationOutline Anti-coagulant and anti-thrombotic drugs Haemostasis and Thrombosis Year 3 Dentistry
Outline Anti-coagulant and anti-thrombotic drugs Year 3 Dentistry Professor Yotis Senis Cellular Haemostasis y.senis@bham.ac.uk I. Haemostasis and II. Coagulation and anti-coagulants III. Platelets and
More information-Hashim ahmed is the one who wrote this sheet. I just edited it according to our record.
* Subjects of this lecture : - Hemostasis - Platelets, general information, their ultrastructure and role in hemostasis. - Definitions: Thrombus, Embolus, Arteriosclerosis and Atherosclerosis. *NOTE: Prof
More informationHemostasis. Clo)ng factors and Coagula4on NORMAL COAGULATION. Overview of blood coagula4on. The Cascade Theory 5/1/12. Clot
Hemostasis Clo)ng factors and Coagula4on Dr Badri Paudel www.badripaudel.com Hemostasis is defined as a property of circula4on whereby blood is maintained within a vessel and the ability of the system
More informationThis slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion
This slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion Topics of today lectures: Hemostasis Meaning of hemostasis Mechanisms
More informationChapter 19. Hemostasis
Chapter 19 Hemostasis Hemostasis Hemostasis is the cessation of bleeding stopping potentially fatal leaks important in small blood vessels not effective in hemorrhage excessive bleeding from large blood
More informationChapter 1 Introduction
Chapter 1 Introduction There are several disorders which carry an increased risk of thrombosis, clots that interfere with normal circulation, including: venous thromboembolism (VTE), comprising both deep
More informationHemostasis and. Blood Coagulation
Hemostasis and Blood Coagulation Events in Hemostasis The term hemostasis means prevention of blood loss. Whenever a vessel is severed or ruptured, hemostasis is achieved by several mechanisms: (1) vascular
More information4/23/2009. September 15, 2008
The Current Treatment of Deep Venous Thrombosis: Are We Doing Enough? George H. Meier, MD Professor and Chief Division of Vascular Surgery University of Cincinnati College of Medicine Cincinnati, Ohio
More informationChapter 3. Haemostatic abnormalities in patients with liver disease
Chapter 3 Haemostatic abnormalities in patients with liver disease Ton Lisman, Frank W.G. Leebeek 1, and Philip G. de Groot Thrombosis and Haemostasis Laboratory, Department of Haematology, University
More informationACQUIRED COAGULATION ABNORMALITIES
ACQUIRED COAGULATION ABNORMALITIES ACQUIRED COAGULATION ABNORMALITIES - causes 1. Liver disease 2. Vitamin K deficiency 3. Increased consumption of the clotting factors (disseminated intravascular coagulation
More informationAnatomy and Physiology
Anatomy and Physiology For The First Class 2 nd Semester Thrombocytes = Platelets Thrombocytes = Platelets Blood platelets are non-nucleated disc like cell fragments 2-4 µm in diameter. Platelets are not
More informationTopics of today lectures: Hemostasis
Topics of today lectures: Hemostasis Meaning of hemostasis Mechanisms of hemostasis - Vascular contraction - Platelets plug - Blood coagulation (clotting) - Structure and functions of platelets - Blood
More informationWHITE PAPERS PRESENTATION VIDEO DOCUMENTATION EXPERIMENT WO NDCLOT. The WoundClot Principals for Effective Bleeding Control PRESENTATION
WHITE PAPERS PRESENTATION VIDEO DOCUMENTATION EXPERIMENT ARTICLES OUR STUDY BLEEDING CONTROL 5 POINT MODEL WO NDCLOT The WoundClot Principals for Effective Bleeding Control PRESENTATION Harnessing SCIENCE
More informationThrombosis. By Dr. Sara Mohamed Abuelgasim
Thrombosis By Dr. Sara Mohamed Abuelgasim 1 Thrombosis Unchecked, blood coagulation would lead to dangerous occlusion of blood vessels if the protective mechanisms of coagulation factor inhibitors, blood
More informationDisseminated Intravascular Coagulation. M.Bahmanpour MD Assistant professor IUMS
به نام خدا Disseminated Intravascular Coagulation M.Bahmanpour MD Assistant professor IUMS Algorithm for Diagnosis of DIC DIC Score factor score Presence of known underlying disorder No= 0 yes=2 Coagolation
More informationAnticoagulants. Pathological formation of a haemostatic plug Arterial associated with atherosclerosis Venous blood stasis e.g. DVT
Haemostasis Thrombosis Phases Endogenous anticoagulants Stopping blood loss Pathological formation of a haemostatic plug Arterial associated with atherosclerosis Venous blood stasis e.g. DVT Vascular Platelet
More informationPHASES OF HAEMOSTASIS
HAEMOSTASIS Maintains the integrity of a closed, highpressure circulatory system after vascular damage Vessel Wall Injury events in the vessel wall and in the blood which seal breach Delicate balance exists
More informationWhat are blood clots?
What are blood clots? Dr Matthew Fay GP Principal The Willows Medical Practice- Queensbury GPwSI and Co-Founder Westcliffe Cardiology Service GP Partner Westcliffe Medical Group Created 5/31/18 Dr. Matthew
More informationPhysiology of. The Blood hemostasis. By prof. Israa f. jaafar
Physiology of The Blood hemostasis By prof. Israa f. jaafar Learning objectives Understand the Platelet structure and function Explane the Platelet production Understand the phases of hemostasis: vascular
More informationPHM142 Lecture 4: Platelets + Endothelial Cells
PHM142 Lecture 4: Platelets + Endothelial Cells 1 Hematopoiesis 2 Platelets Critical in clotting - activated by subendothelial matrix proteins (e.g. collagen, fibronectin, von Willebrand factor) and thrombin
More informationHemostasis and Thrombosis
Hemostasis Hemostasis and Thrombosis Normal hemostasis is a consequence of tightly regulated processes that maintain blood in a fluid state in normal vessels, yet also permit the rapid formation of a hemostatic
More informationApproach to Thrombosis
Approach to Thrombosis Theera Ruchutrakool, M.D. Division of Hematology Department of Medicine Siriraj Hospital Faculty of Medicine Mahidol University Approach to Thrombosis Thrombosis: thrombus formation
More informationAntiphospholipid Syndrome ( APS)
Antiphospholipid Syndrome ( APS) Edward John Walter Bowie, MD Mayo Medical School the first to identify APS as an acquired thrombophilia Graham Robert Vivian Hughes MD FRCP Unit Rayne Institute St Thomas
More informationCoagulation, Haemostasis and interpretation of Coagulation tests
Coagulation, Haemostasis and interpretation of Coagulation tests Learning Outcomes Indicate the normal ranges for routine clotting screen and explain what each measurement means Recognise how to detect
More informationCoagulation Pathway and Physiology
Chapter 1 Coagulation Pathway and Physiology Russell A. Higgins, M Introduction Our understanding of blood clotting is intimately tied to the history of civilization. With the advent of writing 5000 years
More informationMohammadreza Tabatabaei IBTO COAG LAB
Tests for the Evaluation of Lupus Anticoagulants t Mohammadreza Tabatabaei MSc Hematology blood bank MSc Hematology blood bank IBTO COAG LAB Lupus Anticoagulants General Background Lupus anticoagulants
More informationTHROMBOTIC DISORDERS: The Final Frontier
THROMBOTIC DISORDERS: The Final Frontier Jeffrey I. Weitz, MD, FRCP(C), FACP Professor of Medicine and Biochemistry McMaster University Canada Research Chair in Thrombosis Heart & Stroke Foundation/ J.F.
More informationGeneral approach to the investigation of haemostasis. Jan Gert Nel Dept. of Haematology University of Pretoria 2013
General approach to the investigation of haemostasis Jan Gert Nel Dept. of Haematology University of Pretoria 2013 Clinical reasons to investigate haemostasis Investigating a clinically suspected bleeding
More informationBleeding and Haemostasis. Saman W.Boskani HDD, FIBMS Maxillofacial Surgeon
Bleeding and Haemostasis Saman W.Boskani HDD, FIBMS Maxillofacial Surgeon 1 Beeding Its escaping or extravasation of blood contents from blood vessels Types: - Arterial - Venous - Capillary Differences
More informationHaemostasis & Coagulation disorders Objectives:
Haematology Lec. 1 د.ميسم مؤيد علوش Haemostasis & Coagulation disorders Objectives: - Define haemostasis and what are the major components involved in haemostasis? - How to assess the coagulation status?
More informationHematology Review. CCRN exam. The Coagulation Cascade. The Coagulation Cascade. Components include: Intrinsic pathway Extrinsic pathway Common pathway
CCRN exam Hematology Review CCRN Review October 2013 Department of Critical Care Nursing Hematology is 2% of the exam Focus on coagulation cascade, DIC, and HIT Anatomy of the hematologic system Bone marrow
More informationCOAGULATION INHIBITORS LABORATORY DIAGNOSIS OF PROTHROMBOTIC STATES REGULATION OF. ANTICOAGULANT PROTEIN DEFICIENCY Disease entities COAGULATION
LABORATORY DIAGNOSIS OF PROTHROMBOTIC COAGULATION INHIBITORS Tissue Factor Pathway Inhibitor (TFPI) Lipoprotein Associated Coagulation Inhibitor (LACI) Extrinsic Pathway Inhibitor (EPI) Complexes with
More informationHemodynamics. Objectives. Filtration across the endothelium 1/17/2017. K[(P cap - P int )-σ(π cap π int )]
Hemodynamics Amir Kol DVM, Ph.D, Dip ACVP (Clinical Pathology) UC Davis, School of Veterinary Medicine akol@ucdavis.edu Objectives Understand the mechanisms that promote extravascular fluid accumulation
More informationProthrombin Complex Concentrate- Octaplex. Octaplex
Prothrombin Complex Concentrate- Concentrated Factors Prothrombin Complex Concentrate (PCC) 3- factor (factor II, IX, X) 4-factor (factors II, VII, IX, X) Activated 4-factor (factors II, VIIa, IX, X) Coagulation
More informationBleeding and Thrombotic Disorders. Kristine Krafts, M.D.
Bleeding and Thrombotic Disorders Kristine Krafts, M.D. Bleeding and Thrombotic Disorders Bleeding disorders von Willebrand disease Hemophilia A and B DIC TTP/HUS ITP Thrombotic disorders Factor V Leiden
More informationCoagulation Pathway and Physiology
CHAPTER 1 Coagulation Pathway and Physiology Jerry B. Lefkowitz, M Introduction Our understanding of blood clotting is intimately tied to the history of civilization. With the advent of writing 5000 years
More informationCOPYRIGHTED MATERIAL. Overview of h emostasis. Kathleen Brummel Ziedins and Kenneth G. Mann University of Vermont, College of Medicine, VT, USA
1 Overview of h emostasis Kathleen Brummel Ziedins and Kenneth G. Mann University of Vermont, College of Medicine, VT, USA Introduction The maintenance of blood fluidity and protection from blood leakage
More informationThrombophilia. Diagnosis and Management. Kevin P. Hubbard, DO, FACOI
Thrombophilia Diagnosis and Management Kevin P. Hubbard, DO, FACOI Clinical Professor of Medicine Kansas City University of Medicine and Biosciences-College of Osteopathic Medicine Kansas City, Missouri
More informationHEME 10 Bleeding Disorders
HEME 10 Bleeding Disorders When injury occurs, three mechanisms occur Blood vessels Primary hemostasis Secondary hemostasis Diseases of the blood vessels Platelet disorders Thrombocytopenia Functional
More informationDISCLOSURE. Presented by: Merav Sendowski, MD Oregon Health and Science University
Thrombophilia! DISCLOSURE Presented by: Merav Sendowski, MD Oregon Health and Science University Created by: Thomas Deloughery, MD Oregon Health and Science University Current Relevant Financial Relationship(s)
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/28736 holds various files of this Leiden University dissertation. Author: Debeij, Jan Title: The effect of thyroid hormone on haemostasis and thrombosis
More informationTHROMBOPHILIA TESTING: PROS AND CONS SHANNON CARPENTER, MD MS CHILDREN S MERCY HOSPITAL KANSAS CITY, MO
THROMBOPHILIA TESTING: PROS AND CONS SHANNON CARPENTER, MD MS CHILDREN S MERCY HOSPITAL KANSAS CITY, MO DISCLAIMER I m a pediatrician I will be discussing this issue primarily from a pediatric perspective
More informationInstruments smart solutions & service IGZ Instruments AG Räffelstrasse 32 CH 8045 Zürich
ADP (Adenosine-5 -Diphosphate) 101312 3 x 0.5mL ADP is a lyophilized preparation of adenosine-5 -diphosphate. The working concentration of the reconstituted reagent is 2 x 10-4 M. ADP is for use in routine
More informationTrue/False: Idarucizumab can be utilized for the management of bleeding associated with dabigatran.
Discuss the role of idarucizumab for the management of bleeding associated with dabigatran Understand dosing, preparation and administration of idarucizumab I have no financial interest/arrangement or
More informationTHE EFFECT OF ACUTE EXERCISE ON COAGULATION FACTORS AND THE MECHANICAL PROPERTIES OF FIBRIN FIBERS GEORGIA CARROLL HOLLAND
THE EFFECT OF ACUTE EXERCISE ON COAGULATION FACTORS AND THE MECHANICAL PROPERTIES OF FIBRIN FIBERS BY GEORGIA CARROLL HOLLAND A Thesis Submitted to the Graduate Faculty of WAKE FOREST UNIVERSITY GRADUATE
More informationBranch of medicine that deals with blood, its formation and disorders is called. Three main functions of cardiovascular system are,, and.
Chapter 19 The Blood Human body must maintain a balance called. Body fluid inside the cells is called fluid; that outside is called or fluid. Two major fluid networks that help in connecting cells are
More informationHemostasis and fibrinolysis the hemostatic balance
Hemostasis and fibrinolysis the hemostatic balance Bleeding Clotting The hemostatic balance Reference: Boron & Boulpaep Medical Physiology, 3 rd Ed, Chapter 18 Dr. Ana-Maria Zagrean Carol Davila University
More informationJohn Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne
John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne Overview of coagulation Testing coagulation Coagulopathy in ICU Incidence Causes Evaluation Management Coagulation
More informationThe LaboratoryMatters
Laboratory Medicine Newsletter for clinicians, pathologists & clinical laboratory technologists. A Initiative. HEMOSTASIS AND THE LABORATORY This issue highlights: Primary Hemostasis Screening Tests Case
More informationApproach To A Bleeding Patient
ABDUL MAJEED, RAHUL RAJEEV REVIEW ARTICLE INTRODUCTION Hemostasis is the process of forming clots in the walls of damaged blood vessels and preventing blood loss while maintaining blood in a fluid state
More informationBiochemical Reaction Networks and Blood Clotting
Biochemical Reaction Networks and Blood Clotting Yasmeen Hussain, Aaron Fogelson Abstract Following an injury to the walls of a blood vessel, platelet aggregation and blood coagulation are induced. Through
More informationImportant Considera/ons for Coagula/on Tests on Children and Neonates
Important Considera/ons for Coagula/on Tests on Children and Neonates Cindy Neunert, MD MSCS Associate Professor Pediatric Hematology/Oncology/Bone Marrow Transplant Columbia University Medical Center
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091667 Age 37 Years Gender Male 29/8/2017 120000AM 29/8/2017 100129AM 29/8/2017 113851AM Ref By Final COAGULATION ROFILE 1 ARTIAL THROMBOLASTIN TIME, ACTIVATED; ATT
More informationInsights on the Quality of Coagulation Testing
Insights on the Quality of Coagulation Testing Piet Meijer ECAT Foundation The Netherlands No conflicts of interest HAEMOSTATIC BALANCE BLEEDING HAEMOSTATIC BALANCE THROMBOSIS HAEMOSTATIC BALANCE Thrombosis
More informationLaboratory Evaluation of Venous Thrombosis Risk
Laboratory Evaluation of Venous Thrombosis Risk Dorothy M. Adcock, MD Volume 17, Number 12 December 2003 Objective: The reader will be able to discuss the concepts of risk factor, risk potential and thrombotic
More informationPage 1 of 6 THROMBOCYTES
Page 1 of 6 THROMBOCYTES Platelets are not cells in the strict sense. About one-fourth the diameter of a lymphocyte, they are cytoplasmic fragments of extraordinarily large cells (up to 60 µm in diameter)
More informationSupra-Regional Audit Anticoagulation in Palliative Care. 4 th March Denise Farrance
Supra-Regional Audit Anticoagulation in Palliative Care 4 th March 2010 Dr Helen Emms Dr Carolyn Watt Denise Farrance Dr Richard Latten Dr Leslie Johnny Overview Review of current standard & guidelines
More informationThe Effects of Prednisone and Prednisone Plus Ultralow-dose Aspirin on Coagulation Parameters in Healthy Dogs
The Effects of Prednisone and Prednisone Plus Ultralow-dose Aspirin on Coagulation Parameters in Healthy Dogs Allison L. O Kell Thesis submitted to the faculty of the Virginia Polytechnic Institute and
More informationDiscuss the role of idarucizumab for the management of bleeding associated with dabigatran
Discuss the role of idarucizumab for the management of bleeding associated with dabigatran Understand dosing, preparation and administration of idarucizumab I have no financial interest/arrangement or
More informationWhen referring to this work, the full bibliographic details must be given as follows:
RADAR Research Archive and Digital Asset Repository Copyright and Moral Rights for this thesis are retained by the author and/ orother copyright owners. A copy can be downloaded for personal non-commercial
More informationAgent Dose MoA/PK/Admin Adverse events Disadvantages Protamine Heparin: 1mg neutralizes ~ 100 units Heparin neutralization in ~ 5 min
Nanik (Nayri) Hatsakorzian Pharm.D/MPH candidate 2014 Touro University College of Pharmacy CA Bleeding Reversal Agents Agent Dose MoA/PK/Admin Adverse events Disadvantages Protamine Heparin: 1mg neutralizes
More informationReprinted in the IVIS website with the permission of the ACVP and ASVCP
Proceedings of the Annual Meeting of the American College of Veterinary Pathologists and American Society for Veterinary Clinical Pathology - Tucson, Arizona 2006 - Reprinted in the IVIS website with the
More information3/19/2012. What is the indication for anticoagulation? Has the patient previously been on warfarin? If so, what % of the time was the INR therapeutic?
Abigail E. Miller, PharmD, BCPS Clinical Specialist, Cardiology University of North Carolina Hospitals I have no personal financial relationships with the manufacturers of the products to disclose. Boehringer
More informationConsultative Coagulation How to Effectively Answer Common Questions About Hemostasis Testing Session #5000
Consultative Coagulation How to Effectively Answer Common Questions About Hemostasis Testing Session #5000 Dorothy M. (Adcock) Funk, M.D. Karen A. Moser, M.D. Esoterix Coagulation September 20, 2013 Disclosures
More informationCoagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU
Coagulation Disorders Dr. Muhammad Shamim Assistant Professor, BMU 1 Introduction Local Vs. General Hematoma & Joint bleed Coagulation Skin/Mucosal Petechiae & Purpura PLT wound / surgical bleeding Immediate
More informationContinuing Medical Education
Continuing Medical Education WHY DO HEMOPHILIACS BLEED? B.R. Agarwal Z.E. Currimbhoy Deficiency of coagulation factor VIII (antihemophilic factor) and coagulation factor IX (Christmas factor) result in
More informationBoards and Beyond: Hematology
Boards and Beyond: Hematology A Companion Book to the Boards and Beyond Website Jason Ryan, MD, MPH Version date: 12-2-2016 i ii Table of Contents Coagulation 1 Porphyrias 88 Platelet Activation 10 Acute
More informationM B Garvey. University of Toronto
Do I really need that test??? M B Garvey Professor Emeritus University of Toronto St Michael s Hospital No relevant conflicts of interest 1 HEMOSTASIS IS LIKE LOVE Everybody talks about it, nobody understands
More informationfritsmafactor.com Coag QA: Why are we Different? Prothrombin Time 1980: PT Ratio Based on MRI PTR = PTpatient PTMRI
Coag QA: Why are we Different? 4-28-15 Objectives Coagulation Laboratory Quality Assurance Why Are We Different? Compute and report the PT/INR Computing the ISI Local INR validation Local ISI calibration
More informationChapter 4: Haemodynamic disorders, shock
Chapter 4: Haemodynamic disorders, shock 1. Regarding platelets (2006) (a) They are the main source of thrombin (b) they number 150-300 x10 3 per microlitre (c) They contain a nucleus (d) They are biconcave
More informationHemostasis and Thrombosis 2nd Edition
v a d e m e c u m Hemostasis and Thrombosis 2nd Edition Thomas G. DeLoughery, M.D. Oregon Health Sciences University Portland, Oregon, U.S.A. L A N D E S B I O S C I E N C E GEORGETOWN, TEXAS U.S.A. VADEMECUM
More informationRecent studies have found that elevated levels of coagulation
Elevated Hemostatic Factor Levels as Potential Risk Factors for Thrombosis Wayne L. Chandler, MD; George M. Rodgers, MD, PhD; Jason T. Sprouse, MD; Arthur R. Thompson, MD, PhD Recent studies have found
More informationEmergency Blood and Massive Transfusion: The Surgeon s Perspective. Transfusion Medicine Update September 16 17, 2009
Transfusion Medicine Update September 16 17, 2009 Mandip S. Atwal, D.O. FACOS Carl M. Pesta, D.O. FACOS Agenda History Hemorrhagic shock Transfusion is Bad Transfusion Prevention Transfusion The Red Chest
More informationOral Anticoagulant Drugs
Oral Anticoagulant Drugs Spoiled sweet clover caused hemorrhage in cattle(1930s). Substance identified as bishydroxycoumarin. Initially used as rodenticides, still very effective, more than strychnine.
More informationBlood (II) Huawei Liang, PhD
Blood (II) Huawei Liang, PhD E-mail: hwliang@zju.edu.cn Physiological hemostasis 生理止血 The arrest of bleeding from a broken blood vessel -- that is, the stoppage of hemorrhage ( 出血 ) Three major events:
More informationChapter 19 Blood Lecture Outline
Chapter 19 Blood Lecture Outline Cardiovascular system Circulatory system Blood 1. distribution 2. regulation 3. protection Characteristics: ph 7.4 38 C 4-6 L Composition: Plasma Formed elements Erythrocytes
More informationThe Evaluation of Rivaroxaban: A New Oral Anticoagulant in Cats AMY DIXON-JIMENEZ. (Under the Direction of Benjamin M. Brainard) ABSTRACT
The Evaluation of Rivaroxaban: A New Oral Anticoagulant in Cats by AMY DIXON-JIMENEZ (Under the Direction of Benjamin M. Brainard) ABSTRACT Up to 41% of cats diagnosed with hypertrophic cardiomyopathy
More informationReview of the TICH-2 Trial
Review of the TICH-2 Trial Mikaela Hofer, PharmD PGY-1 Pharmacy Resident Pharmacy Grand Rounds September 18, 2018 2018 MFMER slide-1 Objectives Review the pharmacologic options to limit hematoma expansion
More informationBlood Lecture Test Questions Set 2 Summer 2012
Blood Lecture Test Questions Set 2 Summer 2012 1. Leukocytes are attracted to a site of injury or disease by: a. diapedesis b. chemotaxis c. leukocytosis d. heparin e. leukomotosis 2. Leukocytes leave
More informationPlatelet-fibrin clot. 50Kd STEMI. Abciximab. Video of a IIb/IIIa inhibitor in action. Unstable Angina and non-stsegment
Objectives IIb/IIIa, Vitamin K, and Direct Thrombin Inhibition in Cardiology Michael Gulseth, Pharm. D., BCPS Assistant Professor, Duluth Pharmacy 6122 February 14, 2005 Describe the pharmacology, kinetics,
More informationOptimal Utilization of Thrombophilia Testing
Optimal Utilization of Thrombophilia Testing Rajiv K. Pruthi, MBBS Special Coagulation Laboratory & Comprehensive Hemophilia Center Division of Hematology/Internal Medicine Dept of Laboratory Medicine
More informationDetermination of APTT factor sensitivity the misguiding guideline
International Journal of Laboratory Hematology ORIGINAL ARTICLE The Official journal of the International Society for Laboratory Hematology INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY Determination
More informationPART I. Introduction COPYRIGHTED MATERIAL
PART I Introduction COPYRIGHTED MERIAL CHAPTER 1 Overview of h emostasis Kathleen Brummel Ziedins and Kenneth G. Mann University of Vermont, College of Medicine, VT, USA Introduction The maintenance of
More informationMabel Labrada, MD Miami VA Medical Center
Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Shima M, Hanabusa H, Taki M, et al. Factor VIII mimetic function
More information